Pharmacological inhibition of protein kinases that are responsible for the phosphorylation of the carboxy-terminal domain (CTD) of RNA Pol II during transcription by 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole (DRB) leads to severe inhibition of mRNA synthesis and activates p53. Transcription of the p53 effectors that are induced under these conditions, such as p21 or PUMA, must bypass the requirement for CTD phosphorylation by the positive elongation factor P-TEFb. Here, we have downregulated SNW1/SKIP, a splicing factor and a transcriptional co-regulator, which was found to interact with P-TEFb and synergistically affect Tat-dependent transcription elongation of HIV 1. Using the colon cancer derived cell line HCT116, we have found that both doxorubicin- and DRB-induced expression of p21 or PUMA is insensitive to SNW1 downregulation by siRNA. This suggests that transcription of stress response genes, unlike, e.g., the SNW1-sensitive mitosis-specific genes, can proceed uncoupled from regulators that normally function under physiological conditions.

Department of Cell Biology Faculty of Science Charles University Prague Vinicna 7 12843 Prague Czech Republic

Zobrazit více v PubMed

Pluquet O., Hainaut P. Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett. 2001;174:1–15. doi: 10.1016/S0304-3835(01)00698-X. PubMed DOI

Yang H., Wen Y.Y., Zhao R., Lin Y.L., Fournier K., Yang H.Y., Qiu Y., Diaz J., Laronga C., Lee M.H. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res. 2006;66:3096–3105. doi: 10.1158/0008-5472.CAN-05-3620. PubMed DOI

Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 2001;7:683–694. doi: 10.1016/S1097-2765(01)00214-3. PubMed DOI

Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell. 2001;7:673–682. doi: 10.1016/S1097-2765(01)00213-1. PubMed DOI

Muller M., Wilder S., Bannasch D., Israeli D., Lehlbach K., Li-Weber M., Friedman S.L., Galle P.R., Stremmel W., Oren M., Krammer P.H. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 1998;188:2033–2045. doi: 10.1084/jem.188.11.2033. PubMed DOI PMC

Espinosa J.M. Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene. 2008;27:4013–4023. doi: 10.1038/onc.2008.37. PubMed DOI PMC

Hargreaves D.C., Horng T., Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell. 2009;138:129–145. doi: 10.1016/j.cell.2009.05.047. PubMed DOI PMC

Guenther M.G., Levine S.S., Boyer L.A., Jaenisch R., Young R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell. 2007;130:77–88. doi: 10.1016/j.cell.2007.05.042. PubMed DOI PMC

Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., Black J.C., Hoffmann A., Carey M., Smale S.T. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell. 2009;138:114–128. doi: 10.1016/j.cell.2009.04.020. PubMed DOI PMC

Espinosa J.M., Verdun R.E., Emerson B.M. p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol. Cell. 2003;12:1015–1027. doi: 10.1016/S1097-2765(03)00359-9. PubMed DOI

Gomes N.P., Bjerke G., Llorente B., Szostek S.A., Emerson B.M., Espinosa J.M. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev. 2006;20:601–612. doi: 10.1101/gad.1398206. PubMed DOI PMC

Morachis J.M., Murawsky C.M., Emerson B.M. Regulation of the p53 transcriptional response by structurally diverse core promoters. Genes Dev. 2010;24:135–147. doi: 10.1101/gad.1856710. PubMed DOI PMC

Juven-Gershon T., Kadonaga J.T. Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev. Biol. 2010;339:225–229. doi: 10.1016/j.ydbio.2009.08.009. PubMed DOI PMC

Gomes N.P., Espinosa J.M. Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes. Cell Cycle. 2010;9:3428–3437. doi: 10.4161/cc.9.17.12998. PubMed DOI PMC

Gomes N.P., Espinosa J.M. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev. 2010;24:1022–1034. doi: 10.1101/gad.1881010. PubMed DOI PMC

Bres V., Yoh S.M., Jones K.A. The multi-tasking P-TEFb complex. Curr. Opin. Cell Biol. 2008;20:334–340. doi: 10.1016/j.ceb.2008.04.008. PubMed DOI PMC

Lenasi T., Barboric M. P-TEFb stimulates transcription elongation and pre-mRNA splicing through multilateral mechanisms. RNA. Biol. 2010;7:145–150. doi: 10.4161/rna.7.2.11057. PubMed DOI

Turinetto V., Porcedda P., Orlando L., De Marchi M., Amoroso A., Giachino C. The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replicationindependent apoptosis of normal and leukemic cells, regardless of their p53 status. BMC Cancer. 2009;9:281. doi: 10.1186/1471-2407-9-281. PubMed DOI PMC

Medlin J., Scurry A., Taylor A., Zhang F., Peterlin B.M., Murphy S. P-TEFb is not an essential elongation factor for the intronless human U2 snRNA and histone H2b genes. EMBO J. 2005;24:4154–4165. doi: 10.1038/sj.emboj.7600876. PubMed DOI PMC

Garriga J., Xie H., Obradovic Z., Grana X. Selective control of gene expression by CDK9 in human cells. J. Cell Physiol. 2010;222:200–208. doi: 10.1002/jcp.21938. PubMed DOI PMC

Bres V., Gomes N., Pickle L., Jones K.A. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat. Genes Dev. 2005;19:1211–1226. doi: 10.1101/gad.1291705. PubMed DOI PMC

Folk P., Puta F., Skruzny M. Transcriptional coregulator SNW/SKIP: the concealed tie of dissimilar pathways. Cell Mol. Life Sci. 2004;61:629–640. doi: 10.1007/s00018-003-3215-4. PubMed DOI PMC

Makarov E.M., Makarova O.V., Urlaub H., Gentzel M., Will C.L., Wilm M., Luhrmann R. Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science. 2002;298:2205–2208. doi: 10.1126/science.1077783. PubMed DOI

Zhang C., Dowd D.R., Staal A., Gu C., Lian J.B., van Wijnen A.J., Stein G.S., MacDonald P.N. Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J. Biol. Chem. 2003;278:35325–35336. doi: 10.1074/jbc.M305191200. PubMed DOI

Bres V., Yoshida T., Pickle L., Jones K.A. SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Mol. Cell. 2009;36:75–87. doi: 10.1016/j.molcel.2009.08.015. PubMed DOI PMC

Williams C., Edvardsson K., Lewandowski S.A., Strom A., Gustafsson J.A. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene. 2008;27:1019–1032. doi: 10.1038/sj.onc.1210712. PubMed DOI

Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. PubMed DOI

Ambrozkova M., Puta F., Fukova I., Skruzny M., Brabek J., Folk P. The fission yeast ortholog of the coregulator SKIP interacts with the small subunit of U2AF. Biochem. Biophys. Res. Commun. 2001;284:1148–1154. doi: 10.1006/bbrc.2001.5108. PubMed DOI

Hou X., Xie K., Yao J., Qi Z., Xiong L. A homolog of human ski-interacting protein in rice positively regulates cell viability and stress tolerance. Proc. Natl. Acad. Sci. U. S. A. 2009;106:6410–6415. doi: 10.1073/pnas.0901940106. PubMed DOI PMC

Mintz P.J., Patterson S.D., Neuwald A.F., Spahr C.S., Spector D.L. Purification and biochemical characterization of interchromatin granule clusters. EMBO J. 1999;18:4308–4320. doi: 10.1093/emboj/18.15.4308. PubMed DOI PMC

Kim Y.J., Noguchi S., Hayashi Y.K., Tsukahara T., Shimizu T., Arahata K. The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression. Hum. Mol. Genet. 2001;10:1129–1139. doi: 10.1093/hmg/10.11.1129. PubMed DOI

Kadener S., Cramer P., Nogues G., Cazalla D., de la M.M., Fededa J.P., Werbajh S.E., Srebrow A., Kornblihtt A.R. Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing. EMBO J. 2001;20:5759–5768. doi: 10.1093/emboj/20.20.5759. PubMed DOI PMC

Cmarko D., Verschure P.J., Martin T.E., Dahmus M.E., Krause S., Fu X.D., van Driel R., Fakan S. Ultrastructural analysis of transcription and splicing in the cell nucleus after bromo-UTP microinjection. Mol. Biol. Cell. 1999;10:211–223. PubMed PMC

Xie S.Q., Martin S., Guillot P.V., Bentley D.L., Pombo A. Splicing speckles are not reservoirs of RNA polymerase II, but contain an inactive form, phosphorylated on serine2 residues of the C-terminal domain. Mol. Biol. Cell. 2006;17:1723–1733. doi: 10.1091/mbc.E05-08-0726. PubMed DOI PMC

Yang Z., He N., Zhou Q. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol. Cell Biol. 2008;28:967–976. doi: 10.1128/MCB.01020-07. PubMed DOI PMC

Pacheco T.R., Moita L.F., Gomes A.Q., Hacohen N., Carmo-Fonseca M. RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts. Mol. Biol. Cell. 2006;17:4187–4199. doi: 10.1091/mbc.E06-01-0036. PubMed DOI PMC

Neumann B., Walter T., Heriche J.K., Bulkescher J., Erfle H., Conrad C., Rogers P., Poser I., Held M., Liebel U., Cetin C., Sieckmann F., Pau G., Kabbe R., Wunsche A., Satagopam V., Schmitz M.H., Chapuis C., Gerlich D.W., Schneider R., Eils R., Huber W., Peters J.M., Hyman A.A., Durbin R., Pepperkok R., Ellenberg J. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature. 2010;464:721–727. doi: 10.1038/nature08869. PubMed DOI PMC

Kittler R., Putz G., Pelletier L., Poser I., Heninger A.K., Drechsel D., Fischer S., Konstantinova I., Habermann B., Grabner H., Yaspo M.L., Himmelbauer H., Korn B., Neugebauer K., Pisabarro M.T., Buchholz F. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature. 2004;432:1036–1040. doi: 10.1038/nature03159. PubMed DOI

Gahura O., Abrhamova K., Skruzny M., Valentova A., Munzarova V., Folk P., Puta F. Prp45 affects Prp22 partition in spliceosomal complexes and splicing efficiency of non-consensus substrates. J. Cell Biochem. 2009;106:139–151. doi: 10.1002/jcb.21989. PubMed DOI

Ljungman M., Zhang F., Chen F., Rainbow A.J., McKay B.C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene. 1999;18:583–592. doi: 10.1038/sj.onc.1202356. PubMed DOI